The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fenimore Christopher R. since 2018.
This trader's CIK number is 1697422.
At the time of last reporting, Fenimore Christopher R. was the SVP Finance & CFO of Regeneron Pharmaceuticals, Inc.. (stock ticker symbol REGN).
Also see all insider trading activities at Regeneron Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | REGN | 0 | $0 | 10,599 | $11,536,139 | 20,000 | $9,553,300 |
| 2023 | REGN | 0 | $0 | 6,570 | $5,494,394 | 12,000 | $4,149,770 |
| 2022 | REGN | 0 | $0 | 1,844 | $1,381,156 | 19,450 | $8,033,822 |
| 2021 | REGN | 0 | $0 | 4,781 | $3,160,642 | 13,500 | $2,418,255 |
| 2020 | REGN | 0 | $0 | 8,465 | $5,065,238 | 23,330 | $1,853,669 |
| 2019 | REGN | 0 | $0 | 1,682 | $633,212 | 4,000 | $184,169 |
| 2018 | REGN | 0 | $0 | 1,848 | $663,215 | 4,325 | $198,095 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-28 | REGN | Sale | 5,680 | 1,205.76 | 6,848,711 |
| 2024-02-09 | REGN | Sale | 4,919 | 952.92 | 4,687,428 |
| 2024-01-23 | REGN | Option Ex | 10,000 | 477.67 | 4,776,650 |
| 2024-01-03 | REGN | Option Ex | 10,000 | 477.67 | 4,776,650 |
| 2023-12-27 | REGN | Sale | 2,448 | 856.71 | 2,097,226 |
| 2023-12-21 | REGN | Sale | 1,680 | 843.94 | 1,417,819 |
| 2023-12-22 | REGN | Sale | 250 | 846.27 | 211,567 |
| 2023-08-23 | REGN | Option Ex | 7,000 | 399.66 | 2,797,620 |
| 2023-03-23 | REGN | Sale | 2,192 | 806.47 | 1,767,782 |
| 2023-02-03 | REGN | Option Ex | 5,000 | 270.43 | 1,352,150 |
| 2022-10-05 | REGN | Sale | 1,844 | 749.00 | 1,381,156 |
| 2022-04-08 | REGN | Option Ex | 7,450 | 413.05 | 3,077,222 |
| 2022-03-31 | REGN | Option Ex | 12,000 | 413.05 | 4,956,600 |
| 2021-08-23 | REGN | Sale | 4,781 | 661.08 | 3,160,642 |
| 2021-08-20 | REGN | Option Ex | 13,500 | 179.13 | 2,418,255 |
| 2020-07-21 | REGN | Sale | 3,709 | 643.32 | 2,386,077 |
| 2020-07-20 | REGN | Option Ex | 12,224 | 115.58 | 1,412,849 |
| 2020-06-15 | REGN | Option Ex | 9,406 | 41.33 | 388,749 |
| 2020-06-16 | REGN | Sale | 3,556 | 588.96 | 2,094,338 |
| 2020-04-01 | REGN | Option Ex | 1,200 | 30.63 | 36,756 |
| 2020-04-01 | REGN | Sale | 1,200 | 487.35 | 584,823 |
| 2020-01-24 | REGN | Option Ex | 500 | 30.63 | 15,315 |
| 2019-12-20 | REGN | Option Ex | 400 | 30.63 | 12,252 |
| 2019-12-13 | REGN | Sale | 1,682 | 376.46 | 633,212 |
| 2019-12-12 | REGN | Option Ex | 3,100 | 52.03 | 161,293 |
| 2019-04-18 | REGN | Option Ex | 350 | 21.25 | 7,437 |
| 2019-01-18 | REGN | Option Ex | 150 | 21.25 | 3,187 |
| 2018-12-20 | REGN | Sale | 1,848 | 358.88 | 663,215 |
| 2018-12-19 | REGN | Option Ex | 3,450 | 52.03 | 179,503 |
| 2018-12-20 | REGN | Option Ex | 675 | 21.25 | 14,343 |
| 2018-08-30 | REGN | Option Ex | 50 | 21.25 | 1,062 |
| 2018-01-16 | REGN | Option Ex | 150 | 21.25 | 3,187 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fenimore Christopher R. (SVP Finance & CFO of Regeneron Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.